We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Benchtop Technology Designed for Marking, Selecting Cells

By LabMedica International staff writers
Posted on 22 Jan 2013
Print article
Image: The most common jellyfish protein used in lab research glows green when illuminated with UV light (Photo courtesy of NA/TSRI).
Image: The most common jellyfish protein used in lab research glows green when illuminated with UV light (Photo courtesy of NA/TSRI).
Chemists have found a simpler way to perform one of the most essential chores in molecular biology. Their new method allows scientists to add a marker to specific cells, so that these cells may be easily located and/or chosen from a larger cell population.

The technique, which is described in January 2012 in the chemistry journal Angewandte Chemie International Edition, makes use of the tight binding of two proteins that are inexpensively available but are not found in human or other mammalian cells. Therefore, it has advantages over existing cell-marking techniques.

“This new technique is cheap, easy, and sensitive,” said the Scripps Research Institute (TSRI; La Jolla, CA, USA) Prof. Richard A. Lerner, who is the senior author of the new report. “The method should be useful in a variety of applications that require separating out certain types of cells.”

The best-known cell marker currently used is green fluorescent protein (GFP), a protein derived from a jellyfish that emits a characteristic green light when illuminated by specific light wavelengths. When scientists need to add a new gene to cells, for example, to produce a therapeutic protein, they frequently construct a genetic sequence that also includes the GFP gene. Consequently, the cells that effectively produce the new protein will also generate GFP, whose fluorescence allows these cells to be identified and even sorted out from a larger population.

However, fluorescence-based cell sorting is comparatively costly and cumbersome. Alternative cell-marking techniques use marker molecules to which metals or antibodies will bind tightly, but these tend to have annoying side effects on the cells that they mark. Prof. Lerner’s team, led by first author Yingjie Peng, a postdoctoral fellow, set out to devise a better approach.

The new method exploits a special characteristic of chitinase enzymes, which evolved degrade chitin—a rugged, sugar-derived substance found, for example, in squid beaks, crab shells, and the cell walls of fungi. In addition to a main chitin-breaking domain, chitinases have another active structure, a chitin-binding domain (ChBD). “It makes a super-strong bond with chitin,” said Dr. Peng. Recently, scientists have begun to use this high-affinity binding of ChBD and chitin as a marker system, typically for selecting ChBD-tagged proteins in a lab dish. The new method uses ChBD to mark and select cells.

A new gene, in the method, can be added to cells within a larger DNA vector that also includes the genetic sequences for ChBD and GFP. The ChBD molecule will be produced in such a way that it ends up being held on the outer surface of its host cell’s plasma membrane—and the GFP molecule will sit just inside the membrane. The GFP acts as a visual beacon, while the ChBD serves as a handy gripping point for cell selection.

The scientists, after exposing a culture of test cells to this research ChBD-containing vector, were able to visualize, by way of the GFP tags, which cells were expressing them, and was able to pick them out easily, with high sensitivity, utilizing magnetic beads coated with chitin. “This is a relatively easy benchtop method,” Dr. Peng said. Significantly, these selected cells could generate progeny cells that appeared healthy.

Because the ChBD marker, in the vector, is produced in a manner that secures it to a cell’s membrane, it also can serve as a vital application for selecting just the membrane fraction of a sample of cellular material. Dr. Peng and his colleagues showed this using chitin beads to rapidly isolate a pure fraction of membrane material from ChBD-marked test cells. Cellulase enzymes, which degrade the common plant compound cellulose, also have a high-affinity cellulase-binding domain, which can be employed in the same way as the ChBD.

The scientists expect that the new cell-marking method will help to streamline another major molecular biology technique, which was developed by the Lerner laboratory in parallel with the group of Sir Gregory Winter at the Laboratory of Molecular Biology (Cambridge, UK). This technique allows scientists to produce very large and diverse libraries of antibody arms, and to sift through them, or “pan”—in the way miners pan for gold nuggets—for those that might be of use, for example in therapies. ChBD-based markers should be beneficial in boosting the effectiveness of this panning process, according to Dr. Peng.

The investigators are also assessing the potential use of ChBD-based cell marking in living animals, for example, to monitor the outcome of selected cell types throughout an animal’s lifecycle.

Related Links:
Scripps Research Institute


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Immunoassays and Calibrators
QMS Tacrolimus Immunoassays
New
Biological Indicator Vials
BI-O.K.

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.